A5036620011- SARS-CoV-2 and COVID-19 Research
- MicroRNA in disease regulation
- Vaccine Coverage and Hesitancy
- COVID-19 Clinical Research Studies
- RNA modifications and cancer
- Cancer-related molecular mechanisms research
- Long-Term Effects of COVID-19
- Science and Education Research
- COVID-19 and Mental Health
- Infective Endocarditis Diagnosis and Management
- Mosquito-borne diseases and control
- RNA Interference and Gene Delivery
- Viral Infections and Outbreaks Research
- Hepatitis C virus research
- SARS-CoV-2 detection and testing
- Hepatitis Viruses Studies and Epidemiology
- COVID-19 epidemiological studies
- Neonatal and Maternal Infections
- Soil Management and Crop Yield
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Banana Cultivation and Research
- Streptococcal Infections and Treatments
- Extracellular vesicles in disease
- Viral gastroenteritis research and epidemiology
Hospital Israelita Albert Einstein
2015-2023
Lindsay Unified School District
2023
Manhattan Institute for Policy Research
2023
New York Proton Center
2023
Communities In Schools of Orange County
2023
Oregon Medical Research Center
2023
Universidade Estadual de Campinas (UNICAMP)
2016-2017
Universidade de São Paulo
2015-2016
Microsoft (Brazil)
2016
Abstract Objective: To determine risk factors for the development of long coronavirus disease 2019 (COVID-19) in healthcare personnel (HCP). Methods: We conducted a case–control study among HCP who had confirmed symptomatic COVID-19 working Brazilian system between March 1, 2020, and July 15, 2022. Cases were defined as those having COVID according to Centers Disease Control Prevention definition. Controls documented but did not develop COVID. Multiple logistic regression was used assess...
Abstract Background Little is currently known about vaccine effectiveness (VE) for either 2 doses of Oxford-AstraZeneca (ChAdOx1) viral vector or CoronaVac (Instituto Butantan) inactivated followed by a third dose mRNA (Pfizer/BioNTech) among healthcare workers (HCWs). Methods We conducted retrospective cohort study HCWs (aged ≥18 years) working in private system Brazil from January to December 2021. VE was defined as 1 – incidence rate ratio (IRR), with IRR determined using Poisson models...
Abstract Objective: We investigated real-world vaccine effectiveness for Oxford-AstraZeneca (ChAdOx1) and CoronaVac against laboratory-confirmed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers (HCWs). Methods: conducted a retrospective cohort study HCWs (aged ≥18 years) working in private system Brazil between January 1, 2021 August 3, 2021, to assess effectiveness. calculated as 1 − rate ratio (RR), with RR determined by adjusting Poisson models...
ABSTRACT Objectives We aimed to determine risk factors for the development of long coronavirus disease (COVID) in healthcare workers (HCWs). Methods conducted a case-control study among HCWs who had confirmed COVID-19 infection working Brazilian system between March 1, 2020 and July 15, 2022. Cases were defined as those having COVID per Centers Disease Control Prevention definition. Controls documented but did not develop COVID. Multiple logistic regression was used assess association...
During the COVID-19 pandemic, a case of long-term persistence SARS-CoV-2 infection (from March 26 to May 20, 2020) was identified at private hospital in São Paulo, SP, Brazil. The positivity for reverse transcriptase polymerase chain reaction tests patient diagnosed with suggests, least part patients who recovered, may still carry and transmit virus. This fact emphasizes importance having two negative test results SARS-CoV-2. Serological assays were not particularly helpful described, since...
Abstract Objective: To compare the long-term vaccine effectiveness between those receiving viral vector [Oxford-AstraZeneca (ChAdOx1)] or inactivated (CoronaVac) primary series (2 doses) and who received an mRNA booster (Pfizer/BioNTech) (the third dose) among healthcare workers (HCWs). Methods: We conducted a retrospective cohort study HCWs (aged ≥18 years) in Brazil from January 2021 to July 2022. assess variation of dose over time, we estimated rate by taking log risk ratio as function...
OBJECTIVE: Group B Streptococcus (GBS) serotypes (Ia, Ib and II to IX) are classified based on variations in their capsular polysaccharide; prevalence differs between different geographic areas.We examined the of all GBS rectal vaginal swab samples obtained from 363 pregnant women followed at a Brazilian referral center (Hospital da Mulher Professor Doutor José Aristodemo Pinotti); bacterial susceptibility antibiotics was further determined.METHOD: Prevalence positive evaluated by latex...
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
Acute viral hepatitis is a disease of great clinical importance. This study proposes actions to better characterise cases acute in Brazil and provide relevant information institutionalised health policies within the Unified Health System. Available data on need be re-evaluated regarding different hepatotropic agent (hepatitis A E virus) frequencies, as well other agents that can cause similar conditions, such Herpes Simplex Virus 1 2(HSV1, HSV2), Varicella Zoster (VZV), Cytomegalovirus...
A doenca de Chagas, causada pelo protozoario Trypanosoma cruzi, e uma enfermidade que ainda representa um grave problema saude publica. Seu diagnostico realizado com base nos aspectos clinicos, epidemiologicos em testes laboratoriais. Reacao Cadeia da Polimerase (PCR) e, dentre os testes, tecnica alta sensibilidade especificidade, tendo como alvo o kDNA do T. cruzi. O objetivo trabalho foi avaliar a Nested-PCR iniciadores especificos para regiao kDNA, afim evitar resultados falsos-positivos...